Article

[Indications for anticoagulants].

Département de médecine interne et pneumologie Hôpital de la Cavale-Blanche, Brest.
La Revue du praticien 11/1999; 49(15):1648-53. pp.1648-53
Source: PubMed

ABSTRACT Anticoagulant therapy includes heparin, either unfractionned or of low molecular weight, danaparoid, vitamin K antagonists and direct thrombin inhibitors. Low molecular weight heparins are now the cornerstone of venous thromboembolism prevention in surgery, and once daily regimen is available for the treatment of acute deep vein thrombosis. Vitamin K antagonists are mostly used for secondary prevention of venous thromboembolism and for primary prevention of arterial embolism in patients with permanent atrial fibrillation or with cardiac prosthetic valve. Thrombotic complications of heparin-induced thrombocytopenia are prevented and treated by direct thrombin inhibitors or danaparoid.

0 0
 · 
1 Bookmark
 · 
6 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

Anticoagulant therapy
 
arterial embolism
 
cardiac prosthetic valve
 
cornerstone
 
direct thrombin inhibitors
 
heparin-induced thrombocytopenia
 
low molecular weight
 
Low molecular weight heparins
 
patients
 
primary prevention
 
secondary prevention
 
venous thromboembolism
 
venous thromboembolism prevention
 

E Oger